Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil

NCT05034393 is registered in ClinicalTrials.gov with Latin American Cooperative Oncology Group as lead sponsor.

NCT NCT05034393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05034393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil
Lead sponsor
Latin American Cooperative Oncology Group
Phase
Observational
Overall status
Completed
Start date
February 4, 2022
Completion date
February 27, 2023
Enrollment
308 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer